Dock2m1Anu/Dock2m1Anu
C57BL/6JAnu-Dock2m1Anu
|
decreased B cell number |
J:104190
|
decreased T cell number |
J:104190
|
Dock2m1Btlr/Dock2m1Btlr
involves: C57BL/6J
|
abnormal B cell differentiation |
J:173592
|
abnormal class switch recombination |
J:185495
|
abnormal humoral immune response |
J:173592
|
decreased B cell number |
J:185495
|
decreased IgG level |
J:185495
|
decreased T cell number |
J:185495
|
normal
immune system phenotype |
J:185495
|
Dock2m2Anu/Dock2m2Anu
C57BL/6JAnu-Dock2m2Anu
|
abnormal T cell morphology |
J:104190
|
decreased mature B cell number |
J:104190
|
decreased T cell number |
J:104190
|
Dock2m2Btlr/Dock2m2Btlr
C57BL/6J-Dock2m2Btlr
|
abnormal humoral immune response |
J:173670
|
decreased B cell number |
J:173670
|
decreased CD4-positive, alpha-beta T cell number |
J:173670
|
decreased CD8-positive, alpha-beta T cell number |
J:173670
|
Dock2m2Btlr/Dock2m2Btlr
involves: C57BL/6J
|
abnormal B cell differentiation |
J:185495
|
abnormal class switch recombination |
J:185495
|
abnormal humoral immune response |
J:185495
|
decreased B cell number |
J:185495
|
decreased IgG level |
J:185495
|
decreased T cell number |
J:185495
|
normal
immune system phenotype |
J:185495
|
Dock2m3Anu/Dock2m3Anu
C57BL/6NCrlAnu-Dock2m3Anu
|
abnormal CD4-positive, alpha beta T cell morphology |
J:104190
|
abnormal CD8-positive, alpha beta T cell morphology |
J:104190
|
decreased CD4-positive, alpha-beta T cell number |
J:104190
|
Dock2m3Btlr/Dock2m3Btlr
C57BL/6J-Dock2m3Btlr
|
abnormal CD4-positive T cell differentiation |
J:191187
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:191187
|
abnormal humoral immune response |
J:191187
|
abnormal immune system physiology |
J:191187
|
decreased CD4-positive, alpha-beta T cell number |
J:191187
|
decreased CD8-positive, alpha-beta T cell number |
J:191187
|
Dock2m4Btlr/Dock2m4Btlr
C57BL/6J-Dock2m4Btlr
|
abnormal B cell differentiation |
J:221486
|
abnormal CD4-positive T cell differentiation |
J:221486
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:221486
|
Dock2m5Btlr/Dock2+
C57BL/6J-Dock2m5Btlr
|
abnormal CD4-positive T cell differentiation |
J:225938
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:225938
|
decreased CD4-positive, alpha-beta T cell number |
J:225938
|
decreased single-positive T cell number |
J:225938
|
impaired hematopoiesis |
J:225938
|
increased CD8-positive, alpha-beta T cell number |
J:225938
|
increased single-positive T cell number |
J:225938
|
Dock2m5Btlr/Dock2m5Btlr
C57BL/6J-Dock2m5Btlr
|
abnormal B cell differentiation |
J:225938
|
abnormal CD4-positive T cell differentiation |
J:225938
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:225938
|
decreased CD4-positive, alpha-beta T cell number |
J:225938
|
decreased single-positive T cell number |
J:225938
|
impaired hematopoiesis |
J:225938
|
increased B cell number |
J:225938
|
increased CD8-positive, alpha-beta T cell number |
J:225938
|
increased single-positive T cell number |
J:225938
|
Dock2m6Btlr/Dock2m6Btlr
C57BL/6J-Dock2m6Btlr
|
decreased IgE level |
J:236689
|
decreased response to antigen |
J:236689
|
Dock2m7Btlr/Dock2+
C57BL/6J-Dock2m7Btlr
|
decreased B cell number |
J:255181
|
increased macrophage cell number |
J:255181
|
increased neutrophil cell number |
J:255181
|
Dock2m7Btlr/Dock2m7Btlr
C57BL/6J-Dock2m7Btlr
|
decreased B cell number |
J:255181
|
increased IgE level |
J:255181
|
increased macrophage cell number |
J:255181
|
increased neutrophil cell number |
J:255181
|
increased NK cell number |
J:255181
|
Dock2m8Btlr/Dock2m8Btlr
C57BL/6J-Dock2m8Btlr
|
decreased CD4-positive, alpha-beta T cell number |
J:272402
|
increased CD8-positive, alpha-beta T cell number |
J:272402
|
Dock2M9Btlr/Dock2M9Btlr
C57BL/6J-Dock2M9Btlr
|
increased CD8-positive, alpha-beta T cell number |
J:272403
|
Dock2m10Btlr/Dock2m10Btlr
C57BL/6J-Dock2m10Btlr
|
decreased B-1b cell number |
J:272404
|
increased NK cell number |
J:272404
|
Dock2m11Btlr/Dock2m11Btlr
C57BL/6J-Dock2m11Btlr
|
abnormal B cell differentiation |
J:272405
|
abnormal CD4-positive T cell differentiation |
J:272405
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology |
J:272405
|
decreased B cell number |
J:272405
|
decreased CD4-positive, alpha-beta T cell number |
J:272405
|
decreased CD8-positive, naive alpha-beta T cell number |
J:272405
|
decreased NK cell number |
J:272405
|
increased B-1 B cell number |
J:272405
|
increased CD8-positive, alpha-beta T cell number |
J:272405
|
increased central memory CD4-positive, alpha-beta T cell number |
J:272405
|
increased central memory CD8 positive, alpha-beta T cell number |
J:272405
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:272405
|
Dock2M12Btlr/Dock2M12Btlr
C57BL/6J-Dock2M12Btlr
|
decreased B-1a cell number |
J:272406
|
Dock2m13Btlr/Dock2m13Btlr
C57BL/6J-Dock2m13Btlr
|
increased alpha-beta T cell number |
J:272437
|
increased CD8-positive, alpha-beta T cell number |
J:272437
|
Dock2M14Btlr/Dock2M14Btlr
C57BL/6J-Dock2M14Btlr
|
abnormal lymphocyte morphology |
J:272438
|
increased CD8-positive, alpha-beta T cell number |
J:272438
|
Dock2m15Btlr/Dock2m15Btlr
C57BL/6J-Dock2m15Btlr
|
decreased B cell number |
J:274942
|
decreased CD4-positive, alpha-beta T cell number |
J:274942
|
decreased CD8-positive, naive alpha-beta T cell number |
J:274942
|
decreased T cell number |
J:274942
|
increased B-1 B cell number |
J:274942
|
increased CD8-positive, alpha-beta T cell number |
J:274942
|
increased central memory CD8 positive, alpha-beta T cell number |
J:274942
|
increased NK cell number |
J:274942
|
Dock2M16Btlr/Dock2M16Btlr
C57BL/6J-Dock2M16Btlr
|
abnormal CD8-positive, alpha-beta T cell number |
J:274971
|
Dock2tm1b(EUCOMM)Wtsi/Dock2tm1b(EUCOMM)Wtsi
C57BL/6N-Dock2tm1b(EUCOMM)Wtsi/BayMmucd
|
decreased bone mineral density |
J:211773
|
increased spleen weight |
J:211773
|
Dock2tm1Tsas/Dock2tm1Tsas
B6.Cg-Dock2tm1Tsas
|
abnormal cell migration |
J:130919
|
abnormal hematopoietic system morphology/development |
J:130919
|
decreased lymphocyte cell number |
J:130919
|
decreased mature B cell number |
J:130919
|
decreased T cell number |
J:130919
|
impaired neutrophil chemotaxis |
J:113266
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:130919
|
Dock2tm1Tsas/Dock2tm1Tsas
involves: C57BL/6
|
abnormal immune system morphology |
J:71005
|
abnormal leukocyte migration |
J:71005
|
abnormal Peyer's patch morphology |
J:71005
|
abnormal spleen morphology |
J:71005
|
abnormal spleen white pulp morphology |
J:71005
|
decreased marginal zone B cell number |
J:71005
|
lymph node hypoplasia |
J:71005
|
spleen hypoplasia |
J:71005
|